ERAS Program for Minimally Invasive Pancreatic Surgery: Comparing New vs. Traditional Recovery Methods
This important clinical trial compares two different approaches to recovery after minimally invasive pancreatoduodenectomy (removal of part of the pancreas and small intestine). The study will help determine whether a newer, enhanced recovery program (called ERAS) works better than traditional recovery methods for patients undergoing this complex pancreatic surgery.
What is being studied?
The research team wants to know if the ERAS (Enhanced Recovery After Surgery) program helps patients recover faster and with fewer complications compared to standard care. The ERAS group will receive special pre-surgery nutrition, optimized pain management, and earlier eating after surgery. The conventional group will follow typical hospital recovery protocols.
Who can participate?
- Adults (19+) scheduled for minimally invasive pancreatic surgery
- Generally in good health with good physical function
- Willing and able to complete study questionnaires
What does the study involve?
Participants will be randomly assigned to either the ERAS program or conventional care. The main things researchers will measure include:
- How many patients are ready to go home by day 5 after surgery
- Total hospital stay length
- Serious complications within 30 days
- Treatment costs
Why is this research important?
Pancreatic surgery is major operation with significant recovery challenges. Finding ways to help patients heal faster with fewer complications could greatly improve quality of life and reduce healthcare costs. The ERAS approach has shown promise in other types of surgery, but needs proper testing for pancreatic procedures.
General considerations about pancreatic surgery research
Minimally invasive techniques have revolutionized pancreatic surgery in recent years, allowing smaller incisions and potentially faster recovery. However, optimal recovery protocols are still being developed. This study represents an important step in determining the best ways to care for patients after these complex operations. The results could help establish new standards of care that benefit future patients nationwide.
For patients facing pancreatic surgery, understanding recovery expectations is crucial. Research like this helps provide evidence-based approaches to pain management, nutrition, and hospital stay duration. The comparison of costs is particularly valuable as healthcare systems seek to provide high quality care efficiently.
The study's focus on measurable discharge criteria represents an important shift toward objective recovery standards rather than arbitrary hospital stay lengths. This patient-centered approach acknowledges that recovery continues at home and aims to support patients through this transition while maintaining safety.
As pancreatic surgery techniques continue advancing, parallel improvements in recovery protocols are equally important. This research bridges that gap by systematically evaluating comprehensive recovery programs specifically designed for minimally invasive pancreatic procedures.
Upcoming Clinical Trials
-
NCT07803653Not yet recruitingStage IVB Prostate Cancer AJCC v8 | Metastatic Castration-Resistant Prostate Adenocarcinoma
-
NCT07803666Not yet recruitingExercise | Blood Pressure | Nutrition Knowledge
-
NCT07803692Not yet recruiting
-
NCT07803705Not yet recruitingObesity | Overweight | Fatty Pancreas
-
NCT07803718Not yet recruitingPeripheral Artery Disease | Atherectomy in Diseased Lower Extremity Arteries
-
NCT07803731Not yet recruitingSacroiliac Joint Dysfunction
-
NCT07803744Not yet recruitingObesity | Diabetes Mellitus, Type 1 | Overweight
-
NCT07803757Not yet recruitingDental Caries | Cervical Caries
-
NCT07803770Not yet recruitingPancreatic Neoplasms | Radiomics | Pancreatic Ductal Adenocarcinoma (PDAC) | Endoscopic Ultrasound (EUS) | Artificial Intelligence (AI)
-
NCT07803783Not yet recruitingMetastatic Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma (PDAC)
-
NCT07803796Not yet recruitingBody Dysmorhpic Disorder | Positive Psychology
-
NCT07803809RecruitingType 2 Diabetes Mellitus (T2DM) | MASH - Metabolic Dysfunction-Associated Steatohepatitis | Overweight , Obesity